Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

The impact of Allergan implant-related issues on patients with breast implants for reconstruction

Kim JM, Song WJ, Jeong HG, Kang SG

Background In August 2019, the Ministry of Food and Drug Safety and the Korean Society of Plastic and Reconstructive Surgeons confirmed the first case report of breast implant-associated anaplastic large...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The management of breast implant-associated anaplastic large cell lymphoma in the setting of pregnancy: seeking for clinical practice guidelines

Elia R, Maruccia M, Pascale AD, Napoli AD, Ingravallo G, Giudice G

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently described form of T-cell non-Hodgkin lymphoma now formally recognized by the World Health Organization classification of lymphoid neoplasms. The aim...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Breast implant-associated anaplastic large cell lymphoma in an Asian patient: The first case report from Thailand

Thienpaitoon P, Disphanurat W, Warnnissorn N

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has received increasing interest among plastic surgeons as a long-term complication of breast augmentation. Although the prognosis is usually good, mortality is a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Anaplastic Lymphoma Kinase-Negative Primary Gastric Anaplastic Large Cell Lymphoma

Kim HS, Park KW, Lee JL, Bae SH, Do WS, Kim MY, Lee SA

  • KMID: 2263420
  • Korean J Med.
  • 2012 Nov;83(5):674-678.
Primary malignant lymphoma of the stomach comprises 1 to 7% of all gastric malignancies and is mostly B-cell type. Anaplastic large cell lymphoma (ALCL) of the stomach is very rare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr